The EFFECT of MOBILE APPLICATION USE on DIABETES CONTROL in DIABETIC PATIENTS

NCT06620094 | Completed DMC

• 2 other identifiers: Faculty of NursingTSA-2021-2582
• Study Type: interventional
• Target: 38
• Locations: 1 country
• Sites: 1

Brief Summary

Objective:This study aims to determine the effect of a mobile application on diabetes control in patients with Type 2 diabetes. Methods:This study is a randomized controlled trial with a pre-test and post-test design. The study population consists of Type 2 diabetes patients who applied to the Endocrinology Clinic of Malatya Turgut Özal Medical Center. A total of 70 participants were included in the study. Data were collected face-to-face using a demographic data collection form, a diabetes diagnosis and follow-up form, and the Turkish Multidimensional Diabetes Scale. The data were analyzed using paired t-tests and independent samples t-tests to compare means, counts, and percentages in dependent and independent groups.

Conditions

Diabetes

Keywords

Diabetes mellitus, glycated hemoglobin A, mobile applications

Outcome Measures

Primary Outcomes (1)

• A1C levels

  Hemoglobin A1C (HbA1C): HbA1C is a blood test that measures the average blood glucose levels over the past two to three months by determining the percentage of glycated hemoglobin in the blood. It is commonly used to diagnose diabetes and assess the effectiveness of diabetes management. An HbA1C level below 5.7% is considered normal, between 5.7% and 6.4% indicates prediabetes, and a level of 6.5% or higher indicates diabetes.

  up to seven months

Study Arms (2)

Intervention Group

EXPERIMENTAL

This group, used mobile application and underwent routine controls.

Other: diabetes education videos

Control Group

NO INTERVENTION

This group, underwent only routine controls.

Interventions

diabetes education videos OTHER

In the initial meeting during the preparation phase, participants in the experimental group were informed about the notifications and diabetes education videos that would be sent to their phones. Afterward, the patients received three notifications daily, every day of the week. The first notification requested them to ;measure and record their fasting and postprandial blood sugar in the morning; The second notification instructed them to ;exercise for at least 30 minutes a day.; The third notification asked them to ;record the foods they consumed and their quantities, and to measure and record their evening fasting and postprandial blood sugar, as well as their blood sugar before going to bed.; Additionally, during their routine outpatient follow-ups, the results of their tests (A1C, BMI, total cholesterol, HDL, LDL, triglycerides), blood pressure, and weight measurements were recorded. Furthermore, three times a week, participants were asked to ;measure and record their blood pressur

Intervention Group

Eligibility Criteria

• Age: 35 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Having been diagnosed with type 2 diabetes mellitus for at least 6 months. Being between the ages of 40-65. Receiving oral antidiabetic treatment. Having an A1C value between 7%-10%. Owning a mobile phone capable of receiving and playing video messages. Not having sensory impairments, such as hearing or speech loss, or psychiatric problems that prevent communication.

You may not qualify if:

• Inability to use the mobile application. Patients with a psychological diagnosis according to records. Patients using insulin. Having an A1C value above 10%. Having an infection requiring medication.

Sponsors & Collaborators

• Inonu University: lead

Study Sites (1)

Inonu University

Malatya, Malatya, 44280, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Study Officials

• Rukuye AYLAZ, Prof. Dr.

  Inonu University Faculty of Nursing

  STUDY DIRECTOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Asistant

Model Details: This study is a pre-test, post-test randomized controlled experimental study. Therefore this study there is two groups: Intervention and control.

Study Record Dates

• First Submitted: September 24, 2024
• First Posted: October 1, 2024
• Study Start: May 30, 2021
• Primary Completion: December 30, 2021
• Study Completion: December 30, 2021
• Last Updated: October 1, 2024

Record last verified: 2024-09

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)